Navigation Links
Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
Date:9/23/2008

active comparator drugs in the control group.

The integrated safety data presented today includes data from the UPLIFT trial, a study that includes mortality as a pre-specified endpoint. UPLIFT (Understanding Potential Long-term Impacts on Function with Tiotropium), one of the largest COPD trials ever undertaken, involved 5,993 COPD patients from 37 countries around the globe over a four-year treatment period. Patient safety during the trial was closely followed by an independent Data Safety Monitoring Board.

The complete results of the UPLIFT trial will be presented on October 5th during the European Respiratory Society 2008 Annual Congress in Berlin.

About Spiriva(R) HandiHaler(R)

Spiriva HandiHaler is a once-daily inhaled maintenance prescription treatment for breathing problems (airway narrowing) associated with chronic obstructive pulmonary disease (COPD). COPD includes both chronic bronchitis and emphysema.

Spiriva does not replace fast-acting inhalers for sudden symptoms.

Do not swallow the Spiriva capsule. Only use the HandiHaler device to take the Spiriva capsule. Do not use the HandiHaler to take any other medications.

Do not get Spiriva powder in your eyes.

The most common side effect with Spiriva is dry mouth. Others include constipation and problems passing urine. For a complete list of reported side effects, ask your doctor or pharmacist.

Tell your doctor about your medicines, including eye drops, and illnesses like glaucoma and urinary or prostate problems. These may worsen with Spiriva.

If you have vision changes, eye pain, your breathing suddenly worsens, you get hives, or your throat or tongue swells, stop taking Spiriva and contact your doctor.

Do not use Spiriva if you are allergic to atropine, ipratropium, tiotropium bromide, or lactose. A lactose allergy is not the same as lactose intolerance.

Read the step-by-step Patient's Instructions for Use for Spiriva bef
'/>"/>

SOURCE Boehringer Ingelheim; Pfizer Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
2. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
3. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
4. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
5. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
6. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
7. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
8. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
9. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Demers Ambulances is proud to announce it has ... for the states of Mississippi , ... "This will enable Demers to effectively meet ... Executive Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three ... Alabama , giving them a strategic advantage. ...
(Date:9/2/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... amniotic tissue and patent-protected processes to develop and ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... statements published by the Musculoskeletal Transplant Foundation ("MTF") ... MTF,s September 1st press release characterizes ...
(Date:9/2/2015)... , Sept. 2, 2015 Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... initiated expressions of interest, the Company,s Board of Directors ... a review of strategic alternatives to maximize shareholder value. ... and evaluated during the review process may include a ...
Breaking Medicine Technology:Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2MiMedx Corrects A Second Inaccurate MTF Press Release 2MiMedx Corrects A Second Inaccurate MTF Press Release 3Unilife Announces Review of Strategic Alternatives 2
...  MedImmune today announced that the U.S. Food and ... Vaccine Live, Intranasal) for prevention of influenza. The ... quarter of last year.  FluMist Quadrivalent is the ... All other currently available licensed seasonal ...
... Products has finalized its 2012 enhancements of the Hopkins ... has scuff guards, larger wheels and a 2 3/8 ... good bag technique and home healthcare best practice.  It ... pocket and a compartment for the caregiver,s personal items.  ...
Cached Medicine Technology:MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) 2MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) 3Hopkins Medical Products Introduces the Enhanced 2012 Rolling Med Bag 2
(Date:9/3/2015)... , ... September 03, 2015 , ... AvePoint, ... AvePoint Perimeter Service Pack (SP) 4 – AvePoint’s solution for facilitating two-way ... a “KMWorld 2015 Trend-Setting Product”. This is the fifth consecutive year an ...
(Date:9/3/2015)... Gulfport, MS (PRWEB) , ... September 03, 2015 ... ... today that their team will be participating at the highly anticipated Mississippi Gulf ... and expectant mothers coming from all over, from Gulfport, Biloxi, and beyond. We ...
(Date:9/3/2015)... ... ... at the types of people who have a hard time gaining weight , it ... appetite or those that have a fast metabolism. In order to help those people who ... tips for slowing down metabolism. , The first thing to do is to space out ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be hosting an upcoming ... James Earl Jones will introduce a segment that discusses why it is important for ... wellness can be fostered in any working environment. , Employers are out billions of ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... and efficient customer and technical support services to promote LodonalTM in Nigeria. The ... trial evaluating the efficacy and safety of the product. , Managing Director, Fidson ...
Breaking Medicine News(10 mins):Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4
... INCLINE VILLAGE, Nev. , Jan. 28 PDL BioPharma, Inc. (PDL) ... to its stockholders in 2010. Each of the dividends will be $0.50 ... 1, 2010 to all stockholders who own shares of PDL on ... paid on October 1, 2010 to all stockholders who own shares ...
... DETROIT , Jan. 28 Caraco Pharmaceutical Laboratories, Ltd. ... million and $178.4 million for the third quarter ... $55.7 million and $286.2 million , respectively, during the ... quarter and first nine months of Fiscal 2010, in comparison to ...
... medical evaluation for ovarian cancer does not appear to detect ... in only 1 out of 100 women in the general ... January 28 in the Journal of the National Cancer ... Research Center in Seattle assessed the predictive value of certain ...
... College of Physicians (ACP) today urged Congressional leaders to ... care to all Americans and ensure that they have ... shortages." In a letter to key legislators, ACP ... with the President that Congress must complete the task ...
... , ... too common since the disaster hit , ... Bethesda, MD (Vocus) January 28, 2010 -- When a devastating earthquake rocked a ... and its people were rocked too. For years, American Podiatric Medical Association (APMA) ...
... ... Depict the Impact of Macular Degeneration to Increase Awareness of the Leading Cause of ... ... only international organization in the world dedicated exclusively to promoting awareness, treatment and research ...
Cached Medicine News:Health News:PDL BioPharma Announces Two $0.50 Dividends in 2010 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 8Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010 9Health News:Symptoms have little value for early detection of ovarian cancer 2Health News:Congressional leaders urged to reach agreement on health reform 2Health News:Congressional leaders urged to reach agreement on health reform 3Health News:Congressional leaders urged to reach agreement on health reform 4Health News:American Podiatric Medical Association Podiatrists Perform Life-Saving Amputations in Haiti 2Health News:American Podiatric Medical Association Podiatrists Perform Life-Saving Amputations in Haiti 3Health News:AMD Alliance International Announces $10,000 Video Contest 2
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Helmer's Horizon Series line of refrigerator is designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety o...
... Helmer presents the i.Series ... innovative solutions for the ... sophisticated features than ever ... Refrigerators are at the ...
... requirements of blood banking and processing ... meets American Association of Blood Banks ... and U.S. Food & Drug Administration ... platelet incubators feature alarm systems that ...
Medicine Products: